WASHINGTON - A press conference was interrupted on Thursday when one of the attendees fainted in the Oval Office while President Donald Trump was announcing a deal with drugmakers to lower the cost of obesity drugs.

Editor's note: An earlier version of this report, based on information from Getty Images, misidentified the man as a Novo Nordisk employee. This version has been updated based on new information from Novo Nordisk.

What happened?

What we know:

On Thursday, Trump and drugmakers were speaking to the press regarding a deal with Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.

David Ricks, Eli Lilly's CEO, was giving remarks when he looked to his right and said, "Are you OK? Gordon, are you OK?" as one o

See Full Page